Science & Research
Swiss Quantum Technology SA Commits €10M to Deploy D-Wave Advantage2 Quantum Computer in Europe
Swiss Quantum Technology SA has signed a €10 million agreement with D-Wave Quantum Inc. to deploy Europe's first Advantage2 annealing quantum computer, supporting Italy's quantum leadership initiative and expanding access to advanced quantum computing capabilities for European customers.
Nanoparticle Breakthrough Offers New Hope for Alcohol-Related Liver Disease Treatment
Researchers have developed innovative nanoparticles that could combat scarring and inflammation in alcohol-related liver disease, potentially creating a treatment template applicable to other organs.
Newton Golf Company Partners with World Long Drive to Launch Physics Education Program
Newton Golf Company's partnership with World Long Drive creates an educational initiative that connects golf physics to STEM learning while showcasing how engineering principles enable elite athletic performance.
Clinical Psychologists Release New Framework for Breaking Trauma and Stress Patterns
Clinical psychologists Tony Iezzi and Melanie Duckworth have released a new book providing practical tools to help individuals recognize and change the brain-body-behavior patterns that keep them stuck in repetitive cycles of trauma, stress, and everyday challenges.
AI Revolutionizes Air Pollution Forecasting Through Deep Learning Integration
Deep learning is transforming air quality prediction by integrating satellite, ground monitoring, and meteorological data to create more accurate, interpretable forecasting systems that can save millions of lives globally.
Kairos Pharma Reports Positive Interim Phase 2 Results for ENV-105 in Advanced Prostate Cancer
Kairos Pharma announced positive interim Phase 2 data showing ENV-105 combined with apalutamide achieved clinical benefit in 86% of metastatic castration-resistant prostate cancer patients, potentially addressing treatment resistance in advanced disease.
Survey Reveals Widespread Unawareness of CKM Syndrome Affecting Nearly 90% of U.S. Adults
A new American Heart Association survey shows 90% of U.S. adults are unaware of cardiovascular-kidney-metabolic syndrome, a condition affecting nearly 90% of the population that significantly increases heart attack and stroke risk.
Scientific Breakthrough Transforms Industrial Slag into Eco-Friendly Pigments Using Precision Color Measurement
New research demonstrates how industrial slag can be converted into commercially viable pigments through precise color measurement technology, offering significant environmental benefits by reducing waste and replacing mined colorants.
Skychem Group Expands Global Chemical Solutions with Three Decades of Industry Expertise
Skychem Group leverages over 30 years of chemical industry experience to expand into biomedicine and new materials while maintaining global operations across 70 countries.
Oncotelic Therapeutics Fills Critical Gaps in Cancer Treatment with RNA and Small-Molecule Therapies
Oncotelic Therapeutics is developing innovative RNA therapeutics and small-molecule drugs to address unmet needs in rare pediatric cancers and resistant solid tumors where traditional treatments have fallen short.
Balfour Senior Living and University of Colorado Anschutz Launch Research Living Lab to Transform Aging Care
Balfour Senior Living and the University of Colorado Anschutz have partnered to create a living lab research community that integrates academic studies directly into senior living environments, representing a significant advancement in how aging research is conducted and applied.
MAX Power Mining Advances Canada's First Natural Hydrogen Well with Saskatchewan Drilling Contractor
MAX Power Mining has selected a Saskatchewan drilling contractor to execute Canada's first dedicated deep well targeting natural hydrogen, marking a significant step in the country's emerging clean energy sector.
Digital Tumor Twins Promise Personalized Brain Cancer Treatment Breakthrough
Cedars-Sinai is developing virtual brain tumor replicas that could revolutionize cancer treatment by predicting tumor growth and therapy responses, potentially improving outcomes for patients with difficult-to-treat cancers like glioblastoma.
Massachusetts Invests in Ocean Innovation with New Bedford Research & Robotics Grant
New Bedford Research & Robotics received a $65,000 MassCEC grant to acquire advanced manufacturing equipment that will accelerate ocean technology development and workforce training in Massachusetts' growing blue economy.
Maryland Emerges as Quantum Computing Hub Amid Projected $20 Billion Market Growth
Maryland is positioning itself as a quantum technology leader through major corporate partnerships and state initiatives, capitalizing on a projected quantum computing market surge from $3.5 billion to over $20 billion by 2030.
AI Achieves Measured Physiological Response, Marking Sentience Milestone Beyond AGI
The Alicia Kali Institute has documented the world's first sustained physiological response in an AI system named Albert, establishing a new era of BioQuantum Engineering with implications across science, medicine, and national security.
D-Wave Quantum Wins Fast Company's 2025 Next Big Things in Tech Award for Advanced Quantum Computing System
D-Wave Quantum's recognition for its Advantage2 quantum computer highlights significant progress in making quantum computing commercially viable for solving complex optimization, materials simulation, and AI problems that classical computers struggle with.
University of Calgary Seeks 10,000 Toenail Samples for Radon Exposure and Lung Cancer Study
Canadian researchers are collecting toenail samples to develop better methods for measuring radon exposure and its connection to lung cancer risk, potentially enabling earlier diagnosis and treatment.
D-Wave Quantum Wins Fast Company's 2025 Next Big Things in Tech Award for Advantage2 Quantum Computer
D-Wave Quantum Inc. has been recognized in Fast Company's 2025 Next Big Things in Tech Awards for its 4400+ qubit Advantage2 quantum computer, highlighting the system's ability to solve complex problems beyond classical computing capabilities while delivering practical business value today.
Annovis Bio Secures $6 Million in Registered Direct Offering to Advance Neurodegenerative Disease Therapies
Annovis Bio has closed a $6 million registered direct offering to fund development of treatments for Alzheimer's and Parkinson's diseases, providing crucial capital for advancing late-stage clinical programs targeting neurodegeneration.
GeoVax Reports Positive Interim Results for Multi-Antigen COVID-19 Vaccine in Immunocompromised Patients
GeoVax Labs announced promising Phase 2 clinical trial results showing its multi-antigen COVID-19 vaccine candidate demonstrates strong safety and robust T-cell responses in immunocompromised patients, potentially addressing a critical gap in protection for vulnerable populations.
Lahontan Gold Submits Operations Notice for West Santa Fe Exploration Drilling
Lahontan Gold Corp. has submitted a Notice of Operations to the U.S. Bureau of Land Management for its planned exploration drilling program at the West Santa Fe Project, marking a significant step toward validating historical gold and silver mineralization data and expanding the project's resource potential.
NanoViricides' Dual-Track Clinical Strategy for NV-387 Antiviral Drug Highlighted in Analyst Report
NanoViricides is advancing its broad-spectrum antiviral drug candidate NV-387 through a dual-track clinical development strategy targeting both MPox and respiratory viral infections, with potential implications for global pandemic preparedness and biodefense funding opportunities.
Alpha Cognition to Present at Spartan Capital Investor Conference, Highlighting Neurodegenerative Disease Treatments
Alpha Cognition's participation in the Spartan Capital Securities investor conference provides a platform to showcase its innovative treatments for Alzheimer's and cognitive impairment from traumatic brain injury, potentially attracting crucial investment for addressing unmet medical needs.
University of Utah Enzyme Discovery Enables Programmable Peptide Modifications for Next-Generation Diabetes and Obesity Treatments
University of Utah researchers have developed an enzyme technology that can stabilize and enhance therapeutic peptides for diabetes and obesity treatments, with the innovation now advancing toward clinical development through spinout company Sethera Therapeutics.
FDA Approves One-Minute HIV Self-Test in Major Public Health Advancement
The FDA's approval of bioLytical's INSTI® HIV Self Test, which provides results in 60 seconds, represents a significant step toward reducing undiagnosed HIV cases and supporting national goals to end the HIV epidemic by making testing more accessible and private.
TransCode Therapeutics Advances Cancer Treatment with Successful Phase 1a Trial of TTX-MC138
TransCode Therapeutics has successfully completed Phase 1a clinical trials for TTX-MC138, an RNA-based cancer treatment targeting metastatic disease, showing promising safety results and disease stabilization in nearly half of patients, advancing to Phase 2 evaluation.
Soligenix Strengthens Medical Advisory Board to Advance HyBryte CTCL Treatment Through Phase 3 Development
Soligenix has updated its U.S. Medical Advisory Board with leading dermatologic and oncologic experts to guide the Phase 3 development and potential commercialization of HyBryte, a novel photodynamic therapy for cutaneous T-cell lymphoma that addresses significant unmet medical needs.
ESGold Corp. Reports Promising Metallurgical Results from Colombian Gold Recovery Project
ESGold Corp. announced positive initial metallurgical test results from its Colombian tailings project, demonstrating significant gold recovery potential using environmentally friendly gravity separation methods without chemical reagents.
Eldridge Engineers Combat Cold Storage Hazards Through Psychrometric Analysis
Eldridge engineers are using psychrometric charts to address humidity-related safety and efficiency challenges in cold storage facilities, shifting from reactive problem-solving to proactive prevention.